Clinical Trials Browser

OTHER_GOV × Interventional × parsaclisib × Clear all

NCT05083208 2025-12-02

PI3Kδ Inhibitor Parsaclisib Combined With Chidamide for the Treatment of Relapsed/Refractory Peripheral T-cell Lymphoma

Phase 1 Terminated

Lymphoma, T-Cell, Peripheral